The bodyweight walking distance product and its relationship with clinical markers in patients with symptomatic peripheral artery disease

被引:0
|
作者
Santanna, Fernando da Silva [1 ]
Cunha, Paolo M. [3 ]
Costa, Renan Massena [1 ,2 ]
Cucato, Gabriel Grizzo [4 ]
Wolosker, Nelson [3 ]
Dal Corso, Simone [2 ]
Kanegusuku, Helcio [3 ]
Farah, Breno Quintella [5 ]
Ritti-Dias, Raphael Mendes [2 ]
Correia, Marilia de Almeida [1 ,2 ,6 ]
机构
[1] Nove Julho Univ, Postgrad Program Med, Sao Paulo, SP, Brazil
[2] Nove Julho Univ, Postgrad Program Rehabil Sci, Sao Paulo, SP, Brazil
[3] Albert Einstein Israeli Teaching & Res Inst, Sao Paulo, SP, Brazil
[4] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle, England
[5] Univ Fed Rural Pernambuco, Dept Phys Educ, Recife, PE, Brazil
[6] Nove Julho Univ, Rua Vergueiro 235, BR-01504000 Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
THRESHOLD; CAPACITY;
D O I
10.1016/j.jvn.2024.02.002
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Purpose: The six-minute walk test (6MWT) is extensively employed to evaluate gait impairment in patients with symptomatic peripheral artery disease (PAD) and has been associated with different health outcomes. However, various approaches exist for calculating and interpreting the six-minute test in order to address the needs of patients more effectively. Therefore, we investigated how these different approaches correlate with functional capacity and cardiovascular health in patients with symptomatic PAD. Methods: In total, 227 PAD patients [65.2% men and 67 (13) y.o.] were included in this cross-sectional study. The 6MWT was performed along a 30-meter corridor and the distance was expressed in three ways: absolute (described as the meters walked during the test), relativized (based on the results of the 6MWT in healthy individuals), and DW (multiplying the body weight in kilograms by the absolute distance in the 6MWT). A functional capacity z-score was calculated using the results of the handgrip strength test, 4-meter walking test, and sit-and-stand test. A cardiovascular parameter z-score was calculated with data on brachial and central blood pressure, the low-frequency component/high-frequency component ratio, and carotid-femoral pulse wave velocity. Results: The absolute (b = 0.30, 95%CI: 18-0.43, R (2) = 0.11, p < 0.001) and DW (b = 0.40, 95%CI: 270.53, R (2) = 0.17, p < 0.001) measures were related to functional capacity, independently of sex, age, and the ankle-arm index of the patients. Neither absolute nor DW were related to cardiovascular health. The relativized measure was not associated with either functional capacity or cardiovascular health. Conclusion: In patients with symptomatic PAD, absolute and DW measures are related to functional capacity, but not cardiovascular function. (c) 2024 Society for Vascular Nursing, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 50 条
  • [41] Prognostic role of polyvascular involvement in patients with symptomatic peripheral artery disease
    Dopheide, J. F.
    Adam, L.
    Borozadi, M. Khorrami
    Kaspar, M.
    Baumgartner, I
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2363 - 2363
  • [42] Microvascular Pathology Influences Walking Performance in Patients with Peripheral Artery Disease
    Mietus, Constance J.
    Fuglestad, Matthew A.
    Lackner, Timothy J.
    Willcockson, Gregory T.
    Karvelis, Peter
    Hernandez, Hernan
    Gao, Yue
    Brunette, Katyarina
    Despiegelaere, Holly
    Xie, Feng
    Porter, Thomas
    Pipinos, Iraklis
    Casale, George
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [43] Ramipril reduces large artery stiffness and improves walking ability in patients with peripheral arterial disease: A causal relationship?
    Ahimastos, Anna A.
    Dart, Anthony M.
    Lawler, Adam A.
    Blombery, Peter A.
    Kingwell, Bronwyn A.
    CIRCULATION, 2006, 114 (18) : 579 - 579
  • [44] Interactions between vitamin D levels, cardiovascular risk factors, and atherothrombosis markers in patients with symptomatic peripheral artery disease
    Da Porto, Andrea
    Cavarape, Alessandro
    Catena, Cristiana
    Colussi, Gianluca
    Casarsa, Viviana
    Sechi, Leonardo Alberto
    VASCULAR MEDICINE, 2021, 26 (03) : 315 - 316
  • [45] Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease
    Mohler, ER
    Hiatt, WR
    Creager, MA
    CIRCULATION, 2003, 108 (12) : 1481 - 1486
  • [46] Gut Microbial Markers Associated With Clinical Features Of Peripheral Artery Disease
    Niraula, Sarbjeet
    Stirewalt, Spencer L.
    Jung, Jonathan
    Alagna, Megan E.
    Jang, Jae
    Wu, Erik
    Du, James
    Xiong, Liqun
    Green, Stefan J.
    Seed, Patrick C.
    Ho, Karen J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44
  • [47] Effect Of Home-Based Leg Heat Therapy On Walking Performance In Symptomatic Peripheral Artery Disease: A Pilot Randomized Clinical Trial
    Monroe, Jacob
    Perkins, Susan
    Han, Yan
    Motaganahalli, Raghunandan
    Roseguini, Bruno
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41
  • [48] Association of Inflammatory Markers with Multisite Artery Disease in Patients with Peripheral Arterial Disease
    Yalim, Zafer
    Aldemir, Mustafa
    Emren, Sadik Volkan
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2021, 33 (02): : 55 - 61
  • [49] The influence of chronic kidney disease severity on ABI and walking distance in patients with peripheral arterial disease
    Casanegra, Ana I.
    Thompson, David M.
    Montgomery, Polly S.
    Gardner, Andrew W.
    VASCULAR MEDICINE, 2013, 18 (03) : 159 - 159
  • [50] Effects of Exercise Mode on Arterial Stiffness in Symptomatic Peripheral Artery Disease Patients: A Randomized Crossover Clinical Trial
    Dias-Santos, Evans Gleicivan
    Farah, Breno Quintela
    Germano-Soares, Antonio Henrique
    Correia, Marilia de Almeida
    Souza, Allana Andrade
    Hora, Josefa Ediglezia Jesus
    Ritti-Dias, Raphael Mendes
    Andrade-Lima, Aluisio
    ANNALS OF VASCULAR SURGERY, 2021, 74 : 382 - 388